Henrik Ahlbom

614 total citations
17 papers, 347 citations indexed

About

Henrik Ahlbom is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Henrik Ahlbom has authored 17 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Gastroenterology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Henrik Ahlbom's work include Helicobacter pylori-related gastroenterology studies (13 papers), Gastrointestinal Bleeding Diagnosis and Treatment (7 papers) and Gastroesophageal reflux and treatments (5 papers). Henrik Ahlbom is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (13 papers), Gastrointestinal Bleeding Diagnosis and Treatment (7 papers) and Gastroesophageal reflux and treatments (5 papers). Henrik Ahlbom collaborates with scholars based in Sweden, United Kingdom and United States. Henrik Ahlbom's co-authors include James M. Scheiman, Nicholas J. Talley, Neville D. Yeomans, Christopher J. Hawkey, J. Næsdal, Francis K.L. Chan, Nimish Vakil, Kjell–Arne Ung, L Szczepański and D Kleczkowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Henrik Ahlbom

16 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrik Ahlbom Sweden 7 233 193 145 52 46 17 347
S Wetterhus Norway 8 233 1.0× 150 0.8× 159 1.1× 45 0.9× 29 0.6× 15 318
Brigitte Delhotal‐Landes France 10 152 0.7× 92 0.5× 59 0.4× 33 0.6× 25 0.5× 22 340
G Tildesley United Kingdom 8 342 1.5× 197 1.0× 217 1.5× 71 1.4× 85 1.8× 14 527
Rosa Camacho Spain 7 173 0.7× 91 0.5× 28 0.2× 62 1.2× 14 0.3× 15 319
Yuk–Kong Lau China 10 133 0.6× 105 0.5× 88 0.6× 46 0.9× 246 5.3× 11 376
Florence F. Vickers United States 7 244 1.0× 49 0.3× 28 0.2× 119 2.3× 31 0.7× 8 338
Hiroyuki Okamoto Japan 10 679 2.9× 614 3.2× 45 0.3× 303 5.8× 30 0.7× 29 882
Jan Peter Yska Netherlands 10 154 0.7× 17 0.1× 67 0.5× 28 0.5× 33 0.7× 20 326
George Lipscomb United Kingdom 9 80 0.3× 23 0.1× 74 0.5× 21 0.4× 10 0.2× 17 219
Kevin C. Kelly United States 10 205 0.9× 24 0.1× 41 0.3× 36 0.7× 176 3.8× 17 322

Countries citing papers authored by Henrik Ahlbom

Since Specialization
Citations

This map shows the geographic impact of Henrik Ahlbom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Ahlbom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Ahlbom more than expected).

Fields of papers citing papers by Henrik Ahlbom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Ahlbom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Ahlbom. The network helps show where Henrik Ahlbom may publish in the future.

Co-authorship network of co-authors of Henrik Ahlbom

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Ahlbom. A scholar is included among the top collaborators of Henrik Ahlbom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Ahlbom. Henrik Ahlbom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Doll, Michelle, Le Kang, Jibanananda Satpathy, et al.. (2024). A randomized trial comparing the intraoperative durability of double-gloving with Biogel® surgical gloves to 3 comparators. SHILAP Revista de lepidopterología. 4(1). e169–e169.
2.
Jensen, Dennis M., Stefan Eklund, Tore Persson, et al.. (2017). Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial. The American Journal of Gastroenterology. 112(3). 441–446. 39 indexed citations
3.
Kuipers, Ernst J., Joseph J.�Y. Sung, Alan Barkun, et al.. (2010). Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding. Advances in Therapy. 28(2). 150–159. 9 indexed citations
4.
Jensen, Dennis M., Henrik Ahlbom, Stefan Eklund, et al.. (2010). 356: Rebleeding Risk for Oozing Peptic Ulcer Bleeding (PUB) in a Large International Study—A Reassessment Based Upon a Multivariate Analysis. Gastrointestinal Endoscopy. 71(5). AB117–AB117. 5 indexed citations
5.
Sung, Joseph J.�Y., Alan Barkun, Ernst J. Kuipers, et al.. (2009). Effect of Type of Endoscopic Hemostasis and Adjuvant Intravenous Esomeprazole On Peptic Ulcer Re-Bleeding. Gastrointestinal Endoscopy. 69(5). AB118–AB118. 1 indexed citations
6.
Jensen, Dennis M., Robert K. Stuart, Henrik Ahlbom, & Stefan Eklund. (2009). Inter-Observer Agreement On Assessment of Photo Documentation in Bleeding Peptic Ulcer. Gastrointestinal Endoscopy. 69(5). AB186–AB186. 1 indexed citations
7.
Jensen, Dennis M., Robert K. Stuart, Henrik Ahlbom, et al.. (2009). Is There a Subgroup of Patients with Forrest IB (Oozing) Peptic Ulcer Bleeding At Increased Risk of Re-Bleeding?. Gastrointestinal Endoscopy. 69(5). AB118–AB118. 2 indexed citations
8.
Barkun, Alan, Joseph J.�Y. Sung, Ernst J. Kuipers, et al.. (2009). 225 Intravenous Esomeprazole for Prevention of Peptic Ulcer Re-Bleeding in a Predominantly Caucasian Population: Results On Clinical Benefits and Hospital Resource Use. Gastroenterology. 136(5). A–43. 1 indexed citations
9.
Scheiman, James M., Neville D. Yeomans, Nicholas J. Talley, et al.. (2006). Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors. The American Journal of Gastroenterology. 101(4). 701–710. 212 indexed citations
10.
Hawkey, Christopher J., Roger Jones, Neville D. Yeomans, et al.. (2006). Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non‐steroidal anti‐inflammatory drugs. Alimentary Pharmacology & Therapeutics. 25(7). 813–821. 17 indexed citations
11.
Wilder‐Smith, Clive H., et al.. (2005). Intravenous esomeprazole (40???mg and 20???mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies. European Journal of Gastroenterology & Hepatology. 17(2). 191–197. 18 indexed citations
12.
Niazi, Mohammad, Henrik Ahlbom, Anna Karlsson, et al.. (2005). Pharmacokinetics of Esomeprazole Following Varying Intravenous Administration Rates. Basic & Clinical Pharmacology & Toxicology. 97(6). 351–354. 5 indexed citations
13.
Wilder‐Smith, Clive H., et al.. (2005). Intravenous Esomeprazole 40mg is??Effective for the Control of Intragastric Acid Levels Whether Given as a??3-Minute Injection or a 30-Minute Infusion. Clinical Drug Investigation. 25(8). 517–525. 6 indexed citations
14.
Wilder‐Smith, Clive H., et al.. (2004). Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study. Alimentary Pharmacology & Therapeutics. 20(10). 1099–1104. 23 indexed citations
15.
Röhss, Kerstin, et al.. (2004). ESOMEPRAZOLE 40 MG ADMINISTERED INTRAVENOUSLY (I.V.) PROVIDES BETTER CONTROL OF BASAL AND STIMULATED GASTRIC ACID SECRETION THAN OMEPRAZOLE 40 MG ADMINISTERED I.V.. The American Journal of Gastroenterology. 99. S12–S12. 1 indexed citations
16.
Ahlbom, Henrik, et al.. (2003). ESOMEPRAZOLE 40 MG INTRAVENOUS PROVIDES FASTER AND MORE EFFECTIVE ACID CONTROL THAN PANTOPRAZOLE 40 MG INTRAVENOUS AFTER FIRST DOSE AND 5 DAYS. The American Journal of Gastroenterology. 98. S24–S25. 2 indexed citations
17.
Wilder‐Smith, Clive H., et al.. (2003). ESOMEPRAZOLE 20 MG ADMINISTERED AS A 30-MINUTE INFUSION PROVIDES A SIMILAR LEVEL OF ACID CONTROL AS ORAL ADMINISTRATION IN HEALTHY SUBJECTS. The American Journal of Gastroenterology. 98. S21–S21. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Wetterhus Breakdown of academic impact, for papers by Brigitte Delhotal‐Landes Breakdown of academic impact, for papers by G Tildesley Breakdown of academic impact, for papers by Rosa Camacho Breakdown of academic impact, for papers by Yuk–Kong Lau Breakdown of academic impact, for papers by Florence F. Vickers Breakdown of academic impact, for papers by Hiroyuki Okamoto Breakdown of academic impact, for papers by Jan Peter Yska Breakdown of academic impact, for papers by George Lipscomb Breakdown of academic impact, for papers by Kevin C. Kelly
Rankless by CCL
2026